The store will not work correctly when cookies are disabled.
4-(3-Methoxyphenyl)-6-(pyridin-3-yl)pyrimidin-2-amine
ID: ALA4763240
PubChem CID: 162660703
Max Phase: Preclinical
Molecular Formula: C16H14N4O
Molecular Weight: 278.32
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cccc(-c2cc(-c3cccnc3)nc(N)n2)c1
Standard InChI: InChI=1S/C16H14N4O/c1-21-13-6-2-4-11(8-13)14-9-15(20-16(17)19-14)12-5-3-7-18-10-12/h2-10H,1H3,(H2,17,19,20)
Standard InChI Key: BSJUIBHZXACOTG-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
35.2575 -11.8740 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.2564 -12.6935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9644 -13.1025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6741 -12.6931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6712 -11.8704 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.9626 -11.4651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5502 -13.1019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8425 -12.6910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1350 -13.0983 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.1339 -13.9164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8463 -14.3254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5509 -13.9157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3789 -13.0998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3788 -13.9181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0864 -14.3255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7944 -13.9157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7905 -13.0943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0824 -12.6906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4961 -12.6821 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.2059 -13.0871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9602 -10.6479 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
2 7 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
4 13 1 0
17 19 1 0
19 20 1 0
6 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 278.32 | Molecular Weight (Monoisotopic): 278.1168 | AlogP: 2.80 | #Rotatable Bonds: 3 |
Polar Surface Area: 73.92 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.32 | CX LogP: 2.59 | CX LogD: 2.59 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.80 | Np Likeness Score: -1.00 |
References
1. Robinson WJ,Taylor AE,Lauga-Cami S,Weaver GW,Arroo RRJ,Kaiser M,Gul S,Kuzikov M,Ellinger B,Singh K,Schirmeister T,Botana A,Eurtivong C,Bhambra AS. (2021) The discovery of novel antitrypanosomal 4-phenyl-6-(pyridin-3-yl)pyrimidines., 209 [PMID:33070078] [10.1016/j.ejmech.2020.112871] |